Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01703481
Title A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Patients With Advanced or Refractory Solid Tumors or Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

Advanced Solid Tumor

lymphoma

Therapies

Erdafitinib

Age Groups: adult
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Birmingham Alabama United States Details
Tucson Arizona United States Details
La Jolla California United States Details
Los Angeles California United States Details
Sacramento California United States Details
Santa Monica California United States Details
Denver Colorado United States Details
Tampa Florida United States Details
Augusta Georgia United States Details
Chicago Illinois United States Details
Goshen Indiana United States Details
Boston Massachusetts United States Details
Detroit Michigan United States Details
Saint Louis Missouri United States Details
New Brunswick New Jersey United States Details
Albuquerque New Mexico United States Details
Charlotte North Carolina United States Details
Durham North Carolina United States Details
Nashville Tennessee United States Details
Dallas Texas United States Details
Houston Texas United States Details
Tyler Texas United States Details
Fairfax Virginia United States Details
Bordeaux France Details
Caen Cedex 05 France Details
Dijon France Details
Lyon France Details
Marseille France Details
Saint Herblain Cedex France Details
Villejuif France Details
Badalona Spain Details
Barcelona Spain Details
Madrid Spain Details
Málaga Spain Details
Pamplona Spain Details
Sevilla Spain Details
Valencia Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field